HSPA9 and even-plus syndrome: To stabilize the complex for structural analysis, we introduced a point mutation, R126W, into mortalin (mortalinR126W) that is associated with EVEN-PLUS syndrome and has been shown to reduce mortalin’s ATPase activity and conformational flexibility12.